BETAXOLOL MEDREG 20mg tablets medication leaflet

C07AB05 betaxolol • Cardiovascular system | Beta blocking agents | Beta blocking agents, selective

Betaxolol is a beta-blocker medication primarily used for the treatment of high blood pressure and glaucoma. It works by blocking beta-adrenergic receptors, reducing heart rate and blood pressure, as well as intraocular pressure.

In ophthalmology, betaxolol is used as eye drops to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension, thereby preventing optic nerve damage.

In oral form, betaxolol is indicated for the treatment of hypertension and angina pectoris.

Side effects may include eye irritation (for eye drops), fatigue, dizziness, bradycardia (slow heart rate), or, rarely, breathing difficulties. It is contraindicated in patients with severe bradycardia, decompensated heart failure, or severe asthma.

General data about BETAXOLOL MEDREG 20mg

Substance: betaxolol

Date of last drug list: 01-03-2023

Commercial code: W69019010

Concentration: 20mg

Pharmaceutical form: tablets

Quantity: 84

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: SANECA PHARMACEUTICALS A.S. - REPUBLICA SLOVACA

Holder: MEDREG S.R.O. - REPUBLICA CEHA

Number: 14739/2022/10

Shelf life: 5 years

Pharmaceutical forms available for betaxolol

Concentrations available for betaxolol

0.25%, 0.5%, 2.5mg/ml, 20mg, 5mg/ml